Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

3683 Irosustat
19fd3a241974363b759ad47784354bd6d09cbb6a6f3d79ff30b8d50a2ecefbb3

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Properties

Chemistry

Irosustat (, ; developmental code names STX-64, 667-coumate, BN-83495; also known as oristusane) is an orally active, irreversible, nonsteroidal inhibitor of steroid sulfatase (STS) and member of the aryl sulfamate ester class of drugs that was under development by Sterix Ltd and Ipsen for the treatment of hormone-sensitive cancers such as breast cancer, prostate cancer, and endometrial cancer but has not yet been marketed. The drug was first designed and synthesized in the group of Professor Barry V L Potter at the Department of Pharmacy & Pharmacology, University of Bath, working together with Professor Michael J. Reed at Imperial College, London and its initial development was undertaken through the university spin-out company Sterix Ltd and overseen by Cancer Research UK (CRUK). Results of the "first-in-class" clinical trial in breast cancer of an STS inhibitor in humans were published in 2006 and dose optimisation studies and further clinical data have been reported.

From Wikipedia, the free encyclopedia. License: CC BY-SA.
≪ Previous
3682 Next ≫
3684
Made with on Earth by F. Boffa and T. Calemme
This website does not track you.
Read the contract on Etherscan